NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Avivomed

Avivomed

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://avivomed.com/

Last Round

Seed Round

Apr 21, 2026

Total Funding Raised

$32M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Avivomed is a medical device company that develops and commercializes next-generation minimally invasive neuromodulation therapies for patients suffering from obstructive sleep apnea and other chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neuromodulationobstructive sleep apneaOSAmedical deviceimplantable deviceCPAP alternativeminimally invasivesleep apnea treatmentnerve stimulationairway managementclinical-stagesleep techbioelectronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avivomed Comparables

Compare Avivomed with similar companies based on industry and business-model similarity.

Avivomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lunair Medical
94%
XII Medical
92%
StimAire
89%

Avivomed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 21, 2026
Series ADec 1, 2021

Key People

Founding team and executive leadership

Paul Mazanec

CTO VP Of Research Development

Executive Team

Avivomed Investors

Notable investors and investment history

Avivomed investors
InvestorRounds
F-Prime CapitalSeries A
Hatteras Venture PartnersSeries A
Norwest Venture PartnersSeries A
F-Prime CapitalSeries A
Treo VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 369% MoM, reaching 1.5K.

  • Apr 21, 2026

    $5M round raised

Avivomed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avivomed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avivomed's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range18
Year Founded2020
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.